Research on the pathogenic mechanism of pulmonary hypertension (PH) in mixed connective tissue disease (MCTD).

混合性结缔组织病(MCTD)肺动脉高压(PH)发病机制研究。

基本信息

  • 批准号:
    15590312
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

The pathogenesis of pulmonary hypertension (PH) in mixed connective tissue disease (MCTD) is still unclear. Recent studies have suggested that PH in MCTD is resulted from endothelial cell injury. To reveal the pathogenic mechanism of PH in patients with MCTD, this research was focused on anti-endothelial cell antibodies (AECA) and identification of target proteins of AECA.Cyto-ELISA was performed to detect AECA in MCTD patients with PH using micro vascular endothelial cell (HMVEC-L). To determine AECA prevalence, values higher than 2 S.D. above the mean of healthy control were considered as positive. Six of 9 MCTD patients had positive results. The titer of AECA was higher in MCTD patients with PH than without PH.For identification of targets of AECA, proteins from HMVEC-L were separated by two-dimensional electrophoresis and transferred on PVDF membranes. Western blot analyses were performed with sera from healthy control or MCTD patients. Detected protein spots with a difference among the samples were selected and identified by peptide mass finger printing. About 20 protein spots were detected and half of these were identified.As the results of two-dimensional western blot analyses, candidate antigens were obtained. These included proteins reported as autoantigen in various diseases. Furthermore, one of candidates is suggested to be associated with PH in patients with SSc. This raises possibility that the identified proteins include antigens of AECA, indicating that two-dimensional western blot analysis is useful technique for detection of the target antigens of AECA.
混合性结缔组织病(MCTD)中肺动脉高压(PH)的发病机制尚不清楚。最近的研究表明MCTD中的PH是由内皮细胞损伤引起的。为揭示MCTD患者PH的发病机制,本研究重点开展抗内皮细胞抗体(AECA)及其靶蛋白的鉴定。利用Cyto-ELISA技术,利用微血管内皮细胞(HMVEC-L)检测MCTD合并PH患者的AECA。为了确定 AECA 患病率,值高于 2 S.D.高于健康对照的平均值被认为是阳性。 9 名 MCTD 患者中有 6 名结果呈阳性。患有PH的MCTD患者的AECA滴度高于未患有PH的MCTD患者。为了鉴定AECA的靶标,通过二维电泳分离来自HMVEC-L的蛋白质并转移到PVDF膜上。使用健康对照或 MCTD 患者的血清进行蛋白质印迹分析。选择样品中检测到的具有差异的蛋白质点并通过肽质量指纹图谱进行鉴定。检测到约20个蛋白点,其中一半得到鉴定。二维Western blot分析结果,获得候选抗原。其中包括据报道在各种疾病中作为自身抗原的蛋白质。此外,其中一种候选药物被认为与 SSc 患者的 PH 相关。这提出了所鉴定的蛋白质包括AECA抗原的可能性,表明二维蛋白质印迹分析是检测AECA靶抗原的有用技术。

项目成果

期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
血管炎アトラス(尾崎承一、吉木敬編)
血管炎图谱(尾崎翔一、吉木庆编)
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    高橋幸洋;澤井高志
  • 通讯作者:
    澤井高志
Characterization of ANK positive cells in joint tissue from patient with calcium pyrophosphate dihydrate crystal deposition disease (CPPD)
二水焦磷酸钙晶体沉积病 (CPPD) 患者关节组织中 ANK 阳性细胞的特征
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Uzuki M;Sawai T;Ryan LM;Rosenthal A;Masuda I
  • 通讯作者:
    Masuda I
末梢CRFとurocortinの役割-免疫系
外周 CRF 和尿皮质素 - 免疫系统的作用
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    宇月美和;高橋和広;笹野公伸;澤井高志
  • 通讯作者:
    澤井高志
Pulmonary vascular - concept and classification
肺血管 - 概念和分类
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Akira Kurose;Kouyou Takahashi;Takashi Sawai
  • 通讯作者:
    Takashi Sawai
Pulmonary lymphangioleiomyomatosis: A case report with immunohistochemical details and DNA analysis
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAWAI Takashi其他文献

SAWAI Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAWAI Takashi', 18)}}的其他基金

Development of a histopathological learning system for medicine
医学组织病理学学习系统的开发
  • 批准号:
    23501164
  • 财政年份:
    2011
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quantitative analysis of cross-linking amino acid of elastin in aorta and pulmonary artery, associated with aortic aneurysm and pulmonary hypertension, respectively
主动脉和肺动脉弹性蛋白交联氨基酸的定量分析,分别与主动脉瘤和肺动脉高压相关
  • 批准号:
    09670175
  • 财政年份:
    1997
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

PHORA-Pulmonary Hypertension Outcome Risk Assessment
PHORA-肺动脉高压结果风险评估
  • 批准号:
    10990081
  • 财政年份:
    2024
  • 资助金额:
    $ 1.86万
  • 项目类别:
THE ROLE OF EXERCISE DURING HEMODYNAMIC ASSESSMENT TO IMPROVE PULMONARY HYPERTENSION DIAGNOSIS IN OLDER ADULTS
运动在血流动力学评估过程中对改善老年人肺动脉高压诊断的作用
  • 批准号:
    495417
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Standard Grant
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244996
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Standard Grant
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
  • 批准号:
    10642368
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
肺动脉高压:最新技术和治疗机会
  • 批准号:
    10682118
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension
支气管肺发育不良相关肺动脉高压的代谢机制
  • 批准号:
    10736803
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
Early Detection of Right Ventricular Dysfunction and Emerging Pulmonary Hypertension in Systemic Sclerosis
系统性硬化症患者右心室功能障碍和肺动脉高压的早期发现
  • 批准号:
    10585312
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
Resistin regulates NLRP3 inflammasome in pulmonary hypertension
抵抗素调节肺动脉高压中的 NLRP3 炎性体
  • 批准号:
    10567914
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244995
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了